• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Cannabinoids
    2 Drugs classified under this drug class


    All the Drug Class Drugs

    Abbosynagis
    AbbVie
    RX
    partial basket chart
    Abbosynagis

    Cannabinoids, Specific Immunoglobulin. Palvizumab 50 mg, 100mg.
    VIAL(PWDR) + DILUENT: 1 X 50 mg+ 4 ml
    diluent, 100 mg + 10 ml diluent.
    15 mg/kg by I.M. inject. 1 x mthly
    during course of RSV season. See lit.
    Preven. of serious lower resp. tract dis.
    requir. hospitalis. caused by RSV in child.
    at high risk for RSV dis.:
    Child. born at 35 wks. of gestation or less
    and less than 6 mths. of age at the onset
    of the RSV season. Child. less than 2 yrs. of age and requir.
    tmt. for bronchopulm. dysplasia within
    the last 6 mths.
    Children less than 2 yrs. of age and with
    haemodyn. signif.congen. heart dis.
    C/I: Hypersens. to palvizumab or any
    compon. of formula, or other humanized
    monoclonal antibodies.

    Axiban Sublingual Drops IMC-Medical Grade Cannabis Oil
    Rafa
    RX
    not in the basket chart
    Multiple ingredients
    Axiban Sublingual Drops IMC-Medical Grade Cannabis Oil

    Cannabinoids. THC 0.3, 0.9, 1.5, 3, 4.5 mg/drop, CBD 0.6, 0.9, 3, 4.5, 6 mg/drop.
    *This product requires a license for medical cannabis.
    BOTTLE. (sublingual drop.): 10gr (330 drops). Dosage should be adjust. individual.
    The Israel MOH has outlined in Guidance 106 the 12 indicat. for which med. cannabis is indicated. Accord. to this guidance, the 11 indicat. for this product are:
    Chemother-induc. nausea and vomit. (CINV)/ chemother induc. pain.
    Metastat. cancer pain.
    IBD.
    Neuropath. pain.
    Spastic. of MS.
    Pain in Parkinson's dis.
    Cachexia in AIDS.
    Tourette's syndr.
    Recalcitrant epilep. in adult. (Note: Accord. to Guidance 106, med. cannab. is also indic. for recalcitrant epilep. in ped. pts. but this is not an indicat. for this product)
    Palliative care for termin. ill pts.
    Post- traum. stress disord.
    In general, the use of med. cannabis is indicated in pts. who have adequate. tried and failed convent. ther.
    Please refer to Guidance 106 for details.
    In addition, for an individ. pt. with a clinical. signific. med. condit. that cannot be adequate. managed by convent. ther. and which is not includ. as one of the 12 approved indicat. (eg autism, fibromyalgia), the physician can appeal to the MOH Committee for Med. Cannabis to ask for approval on an individ. exception. basis.
    C/I: Prior, current/ family history (1st degr. relative) of psychos. or schizophr. or schizoaffective disord., a hist. of addict. or substance abuse (include. cannabis use disord.or addict. to alcohol), use in preg.or lact., use in pts. <18 yrs. old, bipol.disord., hypersens. to cannabis, coconut oil, palm kernel oil.
    In pts. with hepat. cancer, it is recommend. not to use med. cannab. that contains THC.
    See lit.

    CLOSE